Report Code: A02601 | Pages: 151 | Nov 2018 | 11283 Views | ||
Author(s) : Onkar S | Tables: 87 | Charts: 18 |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Enteric Softgel Capsules Market
Request Now !Enteric Softgel Capsules Market Overview:
The global enteric softgel capsules market was valued at $1,851 million in 2017, and is projected to reach $2,589 million by 2025, registering a CAGR of 4.2% from 2018 to 2025.
A softgel consists of a gelatin-based shell surrounding a liquid or semi-solid (inner fill) drug or extract in the center. Softgel capsules offer several benefits to consumers such as convenience, enhanced efficacy, and bioavailability. Enteric softgel capsules are expected to exhibit significant market growth during the forecast period, owing to rise in adoption of enteric softgel, surge in demand for omega-3 supplements, growth in promotional activities by manufacturers, and rise in consumer awareness for preventative healthcare.
The global enteric softgel capsules market is segmented based on application, sales channel, and region. Based on application, the market is bifurcated as health supplements and pharmaceuticals. According to the sales channel, it is categorized into supermarket & hypermarket, pharmacy & drug store, and online provider. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Segment review
Based on application, the global enteric softgel capsules market is categorized into health supplements and pharmaceuticals. At present, the health supplements segment dominates the global market and is expected to continue this trend during the forecast period. This is attributed to its high adoption, surge in awareness regarding omega-3 supplements, rise in geriatric population, and growth in use of softgel health supplements in emerging economies.
According to sales channel, the global enteric softgel capsules market is segmented into supermarket & hypermarket, pharmacy & drug store, and online provider. The global enteric softgel capsules market was dominated by the pharmacy & drug store segment in 2017 and is expected to continue this trend during the forecast period, due to high presence of these sales channels and easy availability of the products. However, the online provider segment is anticipated to exhibit rapid growth during the forecast period, owing to surge in digital literacy among the general population, and increase in awareness about online pharmacy. Furthermore, these online providers offer various advantages such as fewer expenses, more convenience, and easy access to patient reviews, which drive the market growth of the online provider segment.
Snapshot of Asia-Pacific enteric softgel capsules market Â
Asia-Pacific presents lucrative opportunities to the players operating in the enteric softgel capsules market, owing to high population base, growth in awareness about health supplements, development in healthcare infrastructure, and increase in demand for enteric softgel capsules.
Rise in geriatric population is one of the key reasons that boost the consumption of the enteric softgel health supplements in the Asia-Pacific market. The ability to absorb the required nutrients reduces with the increase in age. Therefore, people have started using dietary supplements to bridge the gap. Furthermore, large patient pool in developing economies such as India, & China and growth in healthcare expenditure due to increase in GDP are projected to create new opportunities during the forecast period. On the other hand, high competition among market players can impede the growth of the Asia-Pacific enteric softgel capsules market.
The key players profiled in this report include BASF SE, Catalent, Inc., Colorcon Inc., Fuji Capsules Co., Ltd., InovoBiologic Inc., NOW Foods Inc., Sirio Pharma Co., Ltd., Super Spectrim, Thermo Fisher Scientific, Inc. (Patheon), and Trigen Laboratories, Inc.
Key Benefits for Enteric Softgel Capsules Market:
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2018 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all the geographical regions is provided to determine the prevailing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
Enteric Softgel Capsules Market Report Highlights
Aspects | Details |
---|---|
By Application |
|
By Sales Channel |
|
By Region |
|
Key Market Players | Fuji Capsules Co., Ltd., Sirio Pharma Co., LTD, BASF SE, Procaps, Catalent, Inc., Thermo Fisher Scientific, Inc. (Patheon), Super Spectrim, Colorcon, Inc., Osmotica Pharmaceuticals plc. (Trigen Laboratories, Inc.), NOW Foods Inc. |
Loading Table Of Content...
Enteric softgel capsules are a form of delayed release dosage form that either protects the drugs from the acidity of the stomach, or the stomach from the detrimental effects of the drug or extract. It is a single-unit solid dosage form consisting of a liquid or semi-solid drug or extract within a soft shell. The adoption of enteric softgel capsules is expected to increase owing to rise in the number of self-directed consumers, growth in demand for omega-3 supplements, and surge in awareness about enteric softgel health supplements in the developing countries.
Rise in R&D activities to develop enteric softgel capsules and increase in consumer awareness related to preventative healthcare are projected to supplement the market growth during the forecast period. Factors such as higher bioavailability, better clinical outcome, and ease of use, fuel the growth of the market. However, complications associated with use of enteric softgel capsules such as, softgel capsulation being unsuitable for hygroscopic drug and extracts are expected to hamper the market growth. Â
North America is expected to remain dominant during the forecast period, on account of the aggrandized use of enteric softgel capsules owing to presence of advanced healthcare facilities, and high healthcare awareness as well as easy product accessibility. In addition, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to the key players during the forecast period owing to developments in healthcare infrastructure with rise in demand for advanced pharmaceuticals and health supplements.
Start reading instantly.
This Report and over 53,643+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers